AlloCure's kidney disease treatment advances Mass High Tech By Michelle Lang The US Food and Drug Administration has granted fast track designation to Burlington biotech startup AlloCure Inc. for AC607, its potential treatment of acute kidney injury (AKI). The treatment, AC607, is a bone marrow-derived ... AlloCure's Investigational Treatment for Acute Kidney Injury Receives Fast ... |
